Mercer Global Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $457K | Buy |
|
|||||
|
2025
Q1 | $447K | Buy |
|
|||||
|
2024
Q4 | $452K | Sell |
|
|||||
|
2024
Q3 | $846K | Buy |
|
|||||
|
2024
Q2 | $833K | Buy |
|
|||||
|
2024
Q1 | $626K | Buy |
|
|||||
|
2023
Q4 | $497K | Buy |
|
|||||
|
2023
Q3 | $384K | Buy |
|
|||||
|
2023
Q2 | $351K | Sell |
|
|||||
|
2023
Q1 | $384K | Buy |
|
|||||
|
2022
Q4 | $365K | Sell |
|
|||||
|
2022
Q3 | $335K | Sell |
|
|||||
|
2022
Q2 | $381K | Buy |
|
|||||
|
2022
Q1 | $442K | Sell |
|
|||||
|
2021
Q4 | $1.06M | Buy |
|
|||||
|
2021
Q3 | $917K | Sell |
|
|||||
|
2021
Q2 | $829K | Buy |
|
|||||
|
2021
Q1 | $219K | Buy |
|